HOME > TOP STORIES
TOP STORIES
-
REGULATORY Bayer Launches Recall of Hemophilia Med Kogenate over Potency Loss
October 4, 2016
-
BUSINESS Mitsubishi Tanabe Looks to Double Late-Stage Pipelines; Faster Decisions Hold Key in Curbing Costs
October 3, 2016
-
REGULATORY MHLW Says It Will Compile “Optimal Use Guidelines” for Keytruda Too
October 3, 2016
-
BUSINESS Suzuken’s Harvoni Sales Sag 70% from Peak, Wholesaler Earnings Certain to Take Hit
September 30, 2016
-
REGULATORY Drug Costs Biggest Driver of Healthcare Spending Surge: Chuikyo JMA Rep
September 29, 2016
-
BUSINESS Tokyo Startup’s Osteoarthritis Drug Hopeful on Tap for PIb Launch by Year-End
September 28, 2016
-
REGULATORY Clinical Research Bill Set to Sail through Extra Diet with Opposition Backing
September 27, 2016
-
TRENDS Japan’s Established Drug Market Shines as Renewed Opportunity for Foreign Generic Firms
September 26, 2016
-
REGULATORY Pharma, Govt Hold 1st Kanmin Taiwa Working Group Talks; Industry Calls for Trial-Friendly Environment, Discussions on Pricing
September 23, 2016
-
BUSINESS Nichi-Iko to Set up Biosimilar Dept. in October to Push Remicade Follow-On
September 21, 2016
-
BUSINESS Eisai Looks to Achieve CAGR of 55% for Fycompa with Add’l Indications
September 20, 2016
-
REGULATORY As Personal Info Law Amendment Looms, Govt Official Tells Drug Makers to Review Info in Hand
September 16, 2016
-
REGULATORY Industry Chiefs, Chuikyo Panelists Trade Barbs over Market Expansion on Add’l Indications
September 15, 2016
-
BUSINESS Novartis Eager to See More 1st Approvals in Japan despite Pricing Headache
September 14, 2016
-
REGULATORY Blue Book “Will Be Used as Reference When Selecting Generics”: Panel Chair
September 14, 2016
-
REGULATORY G7 Health Ministers Adopt Kobe Communique
September 13, 2016
-
REGULATORY Generics from 5 Companies Enough When Major Products Lose Patent Protection: Top Bureaucrat
September 13, 2016
-
BUSINESS Nippon Shinyaku on Track to Achieve Targets in Midterm Plan with Sales of Selexipag Above Expectations: President
September 12, 2016
-
REGULATORY MHLW Panel Backs BI’s Triple Combo After 3rd Try
September 9, 2016
-
BUSINESS Biogen Japan’s Hemophilia Spinoff to Be Up and Running in Early 2017
September 8, 2016
ページ
1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…